Atlas Trials

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Clinical trial NCT02107950 · COMPLETED

Trial details

NCT number
NCT02107950
Sponsor
SOTIO a.s.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian NeoplasmsOvarian Cancer (OvCa)Ovarian Epithelial Cancer
Start date
2013-11-01
Primary completion
2016-11-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.